Announced
Financials
Tags
specialty pharma
United Kingdom
Pharmaceuticals
Private Equity
Majority
Single Bidder
Acquisition
Friendly
Pending
Private
Synopsis
LGC, an international life sciences measurement and testing company, agreed to acquire The Native Antigen Company, a pharmaceutical company, from Mercia Asset Management for $23m. “We are excited to join such a well-respected organisation that shares our purpose and mission, and that will support our diagnostic customers by providing even more world-leading products and services,” Nick Roesen, NAC COO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.